buspirone has been researched along with Obesity in 1 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, D | 1 |
| Pagire, HS | 1 |
| Pagire, SH | 1 |
| Bae, EJ | 1 |
| Dighe, M | 1 |
| Kim, M | 1 |
| Lee, KM | 1 |
| Jang, YK | 1 |
| Jaladi, AK | 1 |
| Jung, KY | 1 |
| Yoo, EK | 1 |
| Gim, HE | 1 |
| Lee, S | 1 |
| Choi, WI | 1 |
| Chi, YI | 1 |
| Song, JS | 1 |
| Bae, MA | 1 |
| Jeon, YH | 1 |
| Lee, GH | 1 |
| Liu, KH | 1 |
| Lee, T | 1 |
| Park, S | 1 |
| Jeon, JH | 1 |
| Lee, IK | 1 |
| Ahn, JH | 1 |
1 other study available for buspirone and Obesity
| Article | Year |
|---|---|
Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases.
Topics: Administration, Oral; Animals; Anthraquinones; Binding Sites; Cell Line; Half-Life; Humans; Hypoglyc | 2019 |